Near-term pressure, but long-term outlook positive

Similar documents
Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Cyient. Good show, priced in NEUTRAL RESULTS REVIEW 4QFY17 21 APRIL Highlights of the quarter

NIIT Technologies. NEUTRAL Higher capex weighing on FCF RESULTS REVIEW 2QFY15 16 OCT 2014

Jubilant FoodWorks NEUTRAL RESULTS REVIEW 4QFY17 30 MAY Highlights of the quarter

Healty cigarette-driven growth

Hexaware Technologies

Jubilant FoodWorks BUY RESULTS REVIEW 1QFY18 18 JULY Highlights of the quarter

BLS International Services

Crompton Greaves Consumer Electricals

Crompton Greaves Consumer Electricals

Bajaj Auto NEUTRAL RESULTS REVIEW 2QFY16 23 OCT Key highlights. CMP (as on 23 Oct 2015) Rs 2,514 Target Price Rs 2,720

Suprajit Engineering. Synergies to accrue BUY COMPANY UPDATE 16 SEP 2016

Weak numbers in peak quarter

Multi Commodity Exchange

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014

Ambuja Cement. Weak numbers SELL RESULTS REVIEW 1QCY17 01 MAY 2017

Intellect Design Arena

Navin Fluorine International

Coromandel International

J. Kumar Infraprojects

Emami NEUTRAL RESULTS REVIEW 4QFY15 14 MAY 2015

Bharat Forge. Cyclical headwinds persist but structural story intact BUY COMPANY UPDATE 9 DEC Key takeaways

Lupin BUY COMPANY UPDATE 12 SEP 2013

Discounting $45/bbl of realisation

Neuland Labs BUY RESULTS REVIEW 1QFY19 12 AUG 2018

Ahluwalia Contracts. Cautious optimism BUY RESULTS REVIEW 4QFY17 31 MAY Highlights of the quarter

Torrent Pharma BUY RESULTS REVIEW 1QFY18 01 AUG 2017

Central Depository Services

NRB Bearings. Strong Show BUY RESULTS REVIEW 4QFY18 23 MAY Highlights of the quarter

Gulf Oil Lubricants BUY RESULTS REVIEW 1QFY19 09 AUG Key highlights

PI Industries BUY RESULTS REVIEW 1QFY19 07 AUG Highlights of the quarter

Navin Fluorine International

Central Depository Services

Sonata Software. On growth path BUY RESULTS REVIEW 1QFY18 16 AUG Highlights of the quarter

Central Depository Services

Sun Pharma BUY RESULTS REVIEW 1QFY19 16 AUG 2018

Real Estate. 4QFY17E Results Preview. 13 Apr Parikshit D Kandpal

Ambuja Cement. Realisations-driven beat SELL RESULTS REVIEW 2QCY17 25 JUL Highlights of the quarter

Maruti Suzuki. A Trough Quarter BUY RESULTS REVIEW 3QFY19 25 JAN CMP(as on 25 Jan 2019) Rs 6,516 Target Price Rs 7,400

Margin boost through non-core book

Oil & Gas. 4QFY17E Results Preview. 13 Apr Deepak Kolhe

Vinati Organics BUY RESULTS REVIEW 2QFY19 29 OCT INDUSTRY CHEMICALS CMP (as on 29 Oct 2018) Rs 1,408 Target Price Rs 1,700

Strong volumes, offset by costs

ITD Cementation (India) Ltd.

Brigade Enterprises BUY RESULTS REVIEW 2QFY16 03 NOV Highlights of the quarter. CMP (as on 03 Nov 2015) Rs 162 Target Price Rs 210

Hindustan Petroleum Corporation

Alkem Labs BUY RESULTS REVIEW 1QFY19 11 AUG story remains on-track. Maintain BUY with a revised TP of Rs 2,410 (24x FY20E EPS).

Carborundum Universal

Hindustan Unilever BUY RESULTS REVIEW 4QFY17 18 MAY 2017

Agrochemicals. 3QFY18E Results Preview 09 JAN Basanth Patil

Music Broadcast. In-line but muted BUY RESULTS REVIEW 2QFY19 26 OCT Key highlights. CMP (as on 26 Oct 2018) Rs 328 Target Price Rs 387

Mahanagar Gas BUY RESULTS REVIEW 1QFY19 01 AUG Highlights of the quarter. CMP (as on 1 Aug 2018) Rs 947 Target Price Rs 1,292

Kalpataru Power Transmission

J. Kumar Infraprojects

Capital Goods. 3QFY18E Results Preview. 10 Jan Sujit Jain

Mphasis. Growth drivers intact BUY RESULTS REVIEW 3QFY19 25 JAN 2019

Geared for version 3.0

Jubilant Life Sciences

Hindustan Petroleum Corporation

Real Estate. 3QFY19E Results Preview. 11 Jan Parikshit D Kandpal, CFA

Alkem Labs BUY RESULTS REVIEW 3QFY19 09 FEB CMP (as on 08 Feb 2019) Rs 1,904 Target Price Rs 2,340. Highlights of the quarter

Chemicals and Fertilisers

ICICI Prudential Life

Cement, Metals & Mining

Tata Steel. JV comes to fruition BUY COMPANY UPDATE 21 SEP Other key highlights. CMP (as on 20 Sep 17) Rs 688 Target Price Rs 818

Exide Industries BUY RESULTS REVIEW 4QFY18 08 MAY Highlights of the quarter. CMP (as on 08 May 2018) Rs 268 Target Price Rs 298

Multi Commodity Exchange

Max Financial. Improving margins! BUY RESULTS REVIEW 4QFY18 30 MAY Highlights of the quarter

Launch momentum picks up

Bharti Infratel BUY RESULT REVIEW 3QFY19 25 JAN 2019

Dishman Carbogen Amcis

CMP* (Rs) 1,464 Upside/ (Downside) (%) 10. Market Cap. (Rs bn) 91 Free Float (%) 55 Shares O/S (mn) 62

Mindtree. Steady quarter, Upside capped NEUTRAL RESULTS REVIEW 4QFY19 18 APR INDUSTRY CMP (as on 16 Apr 2019) Rs 972 Target Price Rs 1,040

Pre-sales pickup key trigger

Crompton Greaves Consumer Electricals

Subros BUY RESULTS REVIEW 2QFY19 30 OCT CMP (as on 29 Oct 2018) Rs 268 TP Rs 435. Key highlights

Dr. Reddy s Labs. Misery continues SELL RESULTS REVIEW 1QFY18 28 JUL 2017

Agriculture. 4QFY18E Results Preview 13 APR Madhukar Ladha

Brigade Enterprises. Stable performance BUY RESULTS REVIEW 2QFY19 14 NOV 2018

Bajaj Auto BUY RESULTS REVIEW 1QFY18 21 JUL Highlights of the quarter

Hero MotoCorp BUY RESULTS REVIEW 2QFY19 16 OCT CMP (as on 16 Oct 2018) Rs 2,898 Target Price Rs 3,602. Highlights of the quarter

Bharat Petroleum Corporation

Dilip Buildcon. Strong comeback BUY RESULT REVIEW 1QFY19 16 AUG Highlights of the quarter. CMP (as on 16 Aug 2018) Rs 847 Target Price Rs 1,434

CMP* (Rs) 360 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 38 Free Float (%) 76 Shares O/S (mn) 104.5

PSP Projects. Marginal miss BUY RESULTS REVIEW 1QFY19 10 AUG 2018

Insecticides India BUY RESULTS REVIEW 4QFY17 30 MAY 2017

JBM Auto. Ready to take off BUY RESULTS REVIEW 1QFY19 07 AUG Key highlights

Multi Commodity Exchange

BUY CDSL. Strong Operating Performance; Maintain BUY. Target Price: Rs435. Institutional Equity Research. 2QFY18 Result Update October 31, 2017

Thangamayil BUY RESULTS REVIEW 2QFY19 15 NOV 2018

Radico Khaitan BUY RESULTS REVIEW 3QFY19 24 JAN 2019

ITC BUY RESULTS REVIEW 1QFY19 27 JUL 2018

Dabur. Bargain hunting BUY COMPANY UPDATE 12 DEC CMP (as on 12 Dec 2013) Rs 168 Target Price Rs 192

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

V-Guard BUY RESULTS REVIEW 3QFY19 02 FEB 2019

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

Construction. 4QFY18E Results Preview 14 APR Parikshit D Kandpal

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Result Update. Sterling Tools. Buy

Transcription:

INDUSTRY IT CMP (as on 2 Nov 2015) Rs 1,812 Target Price Rs 2,050 Nifty 8,051 Sensex 26,559 KEY STOCK DATA Bloomberg ECLX IN No. of Shares (mn) 30 MCap (Rs bn) / ($ mn) 55/843 6m avg traded value (Rs mn) 41 STOCK PERFORMANCE (%) 52 Week high / low Rs 1,989 / 1,170 3M 6M 12M Absolute (%) 22.1 13.7 39.6 Relative (%) 27.7 15.4 44.3 SHAREHOLDING PATTERN (%) Promoters 52.24 FIs & Local MFs 12.14 FIIs 26.98 Public & Others 8.64 Source : BSE Harit Shah haritj.shah@hdfcsec.com +91-22-6171-7325 RESULTS REVIEW 2QFY16 2 NOV 2015 eclerx Services Near-term pressure, but long-term outlook positive eclerx reported its third successive quarter of solid organic USD revenue growth (6.3% QoQ, 6.3% in 4QFY15, 4% in 1QFY16). The company s top-5 client revenue rose 4.9% QoQ, highest in four years, while YoY growth was highest in two years (8.5%). Non-top-5 clients also recorded strong growth (12.7% QoQ, 80.5% YoY). EBIT margin rose 367bps QoQ, the highest since 4QFY14, aided by INR depreciation and lower S&M cost. The management expects flattish revenue over 2HFY16 as short-term projects with large clients in banking and digital sectors are coming to an end. Margins will decline 100-150bps, which may further lead to near-term weakness in share prices. However, we like eclerx s niche business, good use of cash through acquisitions to drive non-top-5 client growth, along with clean a balance sheet and healthy return ratios. We retain our BUY rating, but reduce our TP to Rs 2,050 (Rs 2,190), assigning a lower multiple of 16x BUY 1-year forward rolling EPS (18x) given subdued near-term outlook. Non-top-5 clients again drive revenue: eclerx posted healthy revenue growth of 8.2% QoQ (6.3% organic), aided by non-top-5 client revenues. A significantly positive sign was the growth in the top-5 clients. However, we do not expect this to sustain given the roll offs of some short-term projects in banking and digital. Typically, 10-15% of work done by eclerx is short term (less than 1- year). Cable continues to see strong demand. ConCall takeaways: (1) The management continues to downplay street expectations, mentioning that 2HFY16 revenue will be flattish owing to ending of short-term projects, (2) EBIT margin band in the low 30s likely in 2HFY16 on higher G&A and S&D costs, (3) OCF at Rs 1.7bn in 1HFY16, nearly 2x that of 1HFY15 levels, (4) Roll offs are mainly in the top-5 clients, (5) FY16 has seen bunching up of short-term projects, driving healthy 1H growth, and (5) Cable continues to see strong demand. Financial Summary (Rsmn) 2QFY16 2QFY15 YoY (%) 1QFY16 QoQ (%) FY15 FY16E FY17E FY18E Net Sales 3,285 2,318 41.7 2,983 10.1 9,421 12,994 15,074 17,540 EBIT 1,094 693 57.9 884 23.8 2,656 4,117 4,740 5,464 APAT 927 623 48.8 732 26.6 2,297 3,344 3,724 4,188 Diluted adj. EPS (Rs) 29.9 20.1 48.5 23.7 26.1 74.1 107.9 120.2 135.2 P/E (x) 24.4 16.8 15.1 13.4 EV / EBITDA (x) 16.5 11.5 9.7 8.2 RoE (%) 35.2 41.7 38.0 36.0 # Consolidated HDFC securities Institutional Research is also available on Bloomberg HSLB <GO> & Thomson Reuters

A combination of volume growth of 3% and pricing growth of 9.6% QoQ drove a solid 8.2% QoQ USD revenue growth (6.3% organic) Rupee depreciation boosted INR revenue growth to 10.1% QoQ EBIT margin rose 367bps QoQ on INR depreciation and lower S&M cost Quarterly Consolidated Financials Snapshot Particulars 2QFY16 2QFY15 YoY (%) 1QFY16 QoQ (%) Net Sales 3,285 2,318 41.7 2,983 10.1 Employee Costs 1,562 1,113 40.4 1,488 5.0 SG&A and Other Operating Expenses 502 390 28.6 508 (1.3) EBITDA 1,221 815 49.8 986 23.8 Depreciation 127 122 4.1 102 24.1 EBIT 1,094 693 57.9 884 23.8 Interest Cost 0 0-0 - Other Income 114 104 9.0 166 (31.4) PBT 1,208 797 51.5 1,050 15.0 Tax 279 174 59.8 316 (11.8) Minority Interest 2 0 1 18,629.3 APAT 927 623 48.8 732 26.6 E/o (adj for tax) 0 0 0 RPAT 927 623 48.8 732 26.6 Margin Analysis Particulars 2QFY16 2QFY15 YoY (bps) 1QFY16 QoQ (bps) Employee Expenses % Net Sales 47.6 48.0 (45) 49.9 (233) SG&A and Other Expenses % Net Sales 15.3 16.8 (156) 17.0 (177) EBITDA Margin (%) 37.2 35.2 201 33.1 411 EBIT Margin (%) 33.3 29.9 341 29.6 367 Tax Rate (%) 23.1 21.9 120 30.1 (703) APAT Margin (%) 28.2 26.9 135 24.6 367 Page 2

eclerx saw around 3% volume growth in the quarter, along with 5% improvement in pricing owing to CLX consolidation Volumes And Pricing Particulars 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 Volumes (mn) 2.2 2.3 2.4 2.5 2.7 2.8 Pricing (US$/hour) 16.4 16.6 16.1 16.1 17.0 17.9 Total revenue (US$ mn) 36.2 38.1 38.9 40.7 46.4 50.2 Volumes And Pricing Growth (QoQ, %) 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 Volumes (mn) 5.3 3.8 5.4 4.5 8.0 3.0 Pricing (US$/hour) (3.1) 1.4 (3.1) 0.1 5.6 5.0 Total revenue growth 2.0 5.2 2.1 4.6 14.0 8.2 A negative this quarter was slow growth in North America, even as Europe saw over 25% QoQ USD revenue growth, aided by CLX Geographic Revenue Split (% of revenue) 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 North America 73.0 74.0 78.0 78.0 72.0 67.0 Europe 22.0 23.0 18.0 18.0 25.0 29.0 Rest of the World 5.0 3.0 4.0 4.0 3.0 4.0 Total 100.0 100.0 100.0 100.0 100.0 100.0 Geogrpahic Revenue Growth (QoQ, %) 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 North America 0.6 6.7 7.6 4.6 5.2 0.7 Europe 2.0 10.0 (20.1) 4.6 58.3 25.5 Rest of the World 27.5 (36.9) 36.1 4.6 (14.5) 44.3 Total 2.0 5.2 2.1 4.6 14.0 8.2 Page 3

Non-top-5 clients continued to drive growth, with the % contribution at its highest ever. This has been aided by acquisitions made over the past few years and expansion into newer segments such as digital and cable Total headcount was flat; seat count addition was quite healthy. We expect capex to be on the lower side in 2HFY16 (Rs 355mn in 1H) Client Data (% of revenue) 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 Top-5 clients 70.4 67.7 66.1 63.9 57.5 55.8 Non-top-5 clients 29.6 32.3 33.9 36.1 42.5 44.2 Total 100.0 100.0 100.0 100.0 100.0 100.0 Client Growth (QoQ, %) 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 Top-5 clients (0.8) 1.2 (0.4) 1.2 2.7 4.9 Non-top 5 clients 9.2 15.0 7.3 11.4 34.0 12.7 Total 2.0 5.2 2.1 4.6 14.0 8.2 Headcount, Utilisation Data (Nos.) 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 Total headcount 7,631 7,559 7,839 8,193 8,829 8,824 India employees 7,549 7,469 7,751 8,100 8,747 8,743 - Technical staff 6,623 6,521 6,818 7,095 7,622 7,594 - Support staff 926 948 933 1,005 1,125 1,149 Onsite employees 82 90 88 93 82 81 Net additions 719 (72) 280 354 636 (5) Seat count 7,073 7,341 7,439 7,640 7,806 8,601 Gross staff utilisation (%) 61.0 64.0 65.0 65.0 65.0 67.0 Page 4

Key Assumptions Particulars FY14 FY15 FY16E FY17E FY18E Volume growth (%) 8.8 14.4 19.0 13.7 16.4 Pricing change (%) 4.6 (2.7) 8.4 1.2 0.0 USD revenue growth (%) 13.8 11.3 29.0 15.1 16.4 USD/INR rate 60.81 61.22 65.46 66.00 66.00 EBITDA margin (%) 38.1 28.2 31.7 31.4 31.2 Peer Valuations Company CMP Target Mcap EPS (Rs) P/E (x) RoE (%) Rating (Rs) (Rs) (Rs bn) FY15 FY16E FY17E FY15 FY16E FY17E FY15 FY16E FY17E eclerx 1,812 2,050 BUY 55 74.1 107.9 120.2 24.4 16.8 15.1 35.2 41.7 38.0 Mindtree 1,501 1,410 BUY 126 63.8 74.1 87.0 23.5 20.2 17.3 29.4 27.8 26.9 Cyient 527 558 SELL 59 31.5 34.6 41.2 16.7 15.2 12.8 20.2 19.0 19.9 Hexaware 234 315 BUY 71 10.6 13.7 17.0 22.1 17.1 13.8 25.7 31.2 36.3 KPIT Tech. 140 200 BUY 28 11.4 13.5 17.2 10.8 9.1 7.2 18.4 19.7 21.0 Source: HDFC sec Inst Research Page 5

Consolidated Income Statement Year ending March (Rs mn) FY14 FY15 FY16E FY17E FY18E Net Sales 8,410 9,421 12,994 15,074 17,540 Growth (%) 27.3 12.0 37.9 16.0 16.4 Employee Costs 3,466 4,398 6,297 7,297 8,467 SG&A and Other Operating Exps 1,408 1,867 2,086 2,454 2,961 EBIDTA 3,536 3,156 4,611 5,323 6,111 EBIDTA (%) 42.0 33.5 35.5 35.3 34.8 EBIDTA Growth (%) 38.8 (10.7) 46.1 15.5 14.8 Other Income 110 324 362 236 207 Depreciation 330 500 494 584 648 EBIT 3,316 2,979 4,478 4,976 5,670 Interest 0 0 0 0 0 PBT 3,316 2,979 4,478 4,976 5,670 Tax 759 683 1,127 1,244 1,474 PAT 2,557 2,297 3,351 3,732 4,196 Minority Int & associate profit 0 0 7 8 8 EO items (net of tax) 0 0 0 0 0 APAT 2,557 2,297 3,358 3,740 4,204 APAT Growth (%) 49.0 (10.2) 46.2 11.4 12.4 EPS 82.8 74.1 107.9 120.2 135.2 EPS Growth (%) 45.5 (10.5) 45.6 11.4 12.5 Consolidated Balance Sheet Year ending March (Rs mn) FY14 FY15 FY16E FY17E FY18E SOURCES OF FUNDS Share Capital - Equity 302 304 310 310 310 Reserves 5,588 6,845 8,594 10,369 12,253 Total Shareholders Funds 5,890 7,149 8,904 10,679 12,563 Long Term Provisions & Others 185 233 233 233 233 TOTAL SOURCES OF FUNDS 6,074 7,382 9,137 10,912 12,797 APPLICATION OF FUNDS Net Block 1,548 1,670 3,571 3,591 3,469 CWIP 11 11 11 11 11 Investments, LT Loans & Advances 674 720 720 720 720 Debtors 1,799 2,266 3,195 3,882 4,517 Cash & Equivalents 3,560 4,419 3,504 4,670 6,132 ST Loans & Advances, Others 322 505 505 505 505 Total Current Assets 5,681 7,190 7,204 9,057 11,154 Creditors 11 17 92 134 157 Other Current Liabilities & Provns 1,829 2,192 2,278 2,334 2,402 Total Current Liabilities 1,839 2,210 2,370 2,467 2,558 Net Current Assets 3,842 4,980 4,834 6,590 8,596 TOTAL APPLICATION OF FUNDS 6,074 7,382 9,137 10,912 12,797 Page 6

Consolidated Cash Flow Year ending March (Rs mn) FY14 FY15 FY16E FY17E FY18E Reported PAT 2,557 2,297 3,344 3,724 4,188 Non-operating & EO items 0 0 (419) (8) (8) PAT from Operations 2,557 2,297 2,924 3,716 4,180 Interest expenses 0 0 0 0 0 Depreciation 330 500 494 584 648 Working Capital Change (797) (678) (769) (589) (544) OPERATING CASH FLOW ( a ) 2,090 2,119 2,649 3,710 4,284 Capex (539) (624) (520) (603) (526) Free cash flow (FCF) 1,550 1,494 2,129 3,107 3,758 Investments 0 0 0 0 0 INVESTING CASH FLOW ( b ) (539) (624) (520) (603) (526) Debt Issuance 0 0 0 0 0 Interest expenses 0 0 0 0 0 FCFE 1,550 1,494 2,129 3,107 3,758 Share capital Issuance 3 2 6 0 0 Dividend (880) (1,240) (1,595) (1,949) (2,304) FINANCING CASH FLOW ( c ) (877) (1,239) (1,589) (1,949) (2,304) NET CASH FLOW (a+b+c) 673 256 541 1,158 1,454 Non-operating and EO items 0 0 (1,868) 8 8 Closing Cash & Equivalents 3,022 3,278 1,951 3,117 4,579 Key Ratios FY14 FY15 FY16E FY17E FY18E PROFITABILITY (%) EBITDA Margin 42.0 33.5 35.5 35.3 34.8 APAT Margin 30.4 24.4 25.7 24.7 23.9 RoE 49.8 35.2 41.7 38.0 36.0 RoIC or Core RoCE 56.8 39.6 38.5 40.8 43.8 RoCE 48.1 31.4 38.4 36.3 34.8 EFFICIENCY Tax Rate (%) 22.9 22.9 25.2 25.0 26.0 Asset Turnover (x) 1.1 1.0 1.1 1.1 1.1 Debtors (days) 78 88 90 94 94 Payables (days) 1 1 4 5 5 Cash Conversion Cycle (days) 77 87 86 89 89 Net Debt/EBITDA (x) (1.0) (1.4) (0.8) (0.9) (1.0) Net Debt/Equity (x) (0.6) (0.6) (0.4) (0.4) (0.5) Interest Coverage (x) N.A. N.A. N.A. N.A. N.A. PER SHARE DATA EPS (Rs/sh) 82.8 74.1 107.9 120.2 135.2 CEPS (Rs/sh) 95.3 92.3 126.7 142.2 159.6 DPS (Rs/sh) 25.3 35.0 45.0 55.0 65.0 BV (Rs/sh) 194.4 236.0 293.9 352.5 414.7 VALUATION P/E 21.9 24.4 16.8 15.1 13.4 P/BV 9.3 7.7 6.2 5.1 4.4 EV/EBITDA 14.7 16.5 11.5 9.7 8.2 OCF/EV (%) 4.0 4.1 5.0 7.2 8.5 FCF/EV (%) 3.0 2.9 4.0 6.0 7.5 FCFE/mkt cap (%) 2.8 2.7 3.9 5.7 6.8 Dividend Yield (%) 1.4 1.9 2.5 3.0 3.6 Page 7

Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 ECLERX SERVICES: RESULTS REVIEW 2QFY16 RECOMMENDATION HISTORY 2,400 eclerx 2,200 2,000 1,800 1,600 1,400 1,200 TP Date CMP Reco Target 31-Jan-15 1,282 BUY 1,420 22-Sep-15 1,651 BUY 2,056 8-Oct-15 1,674 BUY 2,190 2-Nov-15 1,812 BUY 2,050 1,000 Rating Definitions BUY : Where the stock is expected to deliver more than 10% returns over the next 12 month period NEUTRAL : Where the stock is expected to deliver (-)10% to 10% returns over the next 12 month period SELL : Where the stock is expected to deliver less than (-)10% returns over the next 12 month period Page 8

Disclosure: I, Harit Shah, PGDBA, author and the name subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does not have any material conflict of interest. Any holding in stock No Disclaimer: This report has been prepared by HDFC Securities Ltd and is meant for sole use by the recipient and not for circulation. The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. This document is for information purposes only. Descriptions of any company or companies or their securities mentioned herein are not intended to be complete and this document is not, and should not be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject HDFC Securities Ltd or its affiliates to any registration or licensing requirement within such jurisdiction. If this report is inadvertently send or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or published for any purposes without prior written approval of HDFC Securities Ltd. Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. HDFC Securities Ltd may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail and/or its attachments. HDFC Securities and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. HDFC Securities Ltd, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. HDFC Securities Ltd and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report. HDFC Securities or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months. HDFC Securities or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in the normal course of business. HDFC Securities or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HDFC Securities nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HDFC Securities may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report. HDFC securities Institutional Equities Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park, Senapati Bapat Marg, Lower Parel,Mumbai - 400 013 Board : +91-22-6171-7330 www.hdfcsec.com Page 9